Abstract
| Language | English |
|---|---|
| Pages | O1295-U2200 |
| Number of pages | 9 |
| Journal | Acta Crystallographica Section E: Structure Reports |
| Volume | 64 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Jul 2008 |
Fingerprint
Keywords
- single-crystal X-ray study
- T = 160 K
- mean (C–C) = 0.002 A°
- R factor = 0.041
- wR factor = 0.089
- data-to-parameter ratio = 18.0
- parallel crystallization
- packing motifs
- carbamazepine
- 10
- 11-dihydrocarbamazepine
- patterns
Cite this
}
Cytenamide-butyric acid (1/1). / Johnston, A.; Florence, A.J.; Fabbiani, F.J.A.; Shankland, K.; Bedford, C.T.
In: Acta Crystallographica Section E: Structure Reports, Vol. 64, No. 7, 07.2008, p. O1295-U2200.Research output: Contribution to journal › Article
TY - JOUR
T1 - Cytenamide-butyric acid (1/1)
AU - Johnston, A.
AU - Florence, A.J.
AU - Fabbiani, F.J.A.
AU - Shankland, K.
AU - Bedford, C.T.
PY - 2008/7
Y1 - 2008/7
N2 - Cytenamide forms a 1:1 solvate with butyric acid [systematic name: 5H-dibenzo[a,d]cycloheptatriene-5-carboxamide-butanoic acid (1/1)], C16H13NO·C4H8O2. The title compound crystallizes with one molecule of cytenamide and one of butyric acid in the asymmetric unit; these molecules are linked by N-HO and O-HO hydrogen bonds to form an R22(8) heterodimer motif. Pairs of adjacent motifs are further connected via N-HO interactions to form a discrete centrosymmetric assembly.
AB - Cytenamide forms a 1:1 solvate with butyric acid [systematic name: 5H-dibenzo[a,d]cycloheptatriene-5-carboxamide-butanoic acid (1/1)], C16H13NO·C4H8O2. The title compound crystallizes with one molecule of cytenamide and one of butyric acid in the asymmetric unit; these molecules are linked by N-HO and O-HO hydrogen bonds to form an R22(8) heterodimer motif. Pairs of adjacent motifs are further connected via N-HO interactions to form a discrete centrosymmetric assembly.
KW - single-crystal X-ray study
KW - T = 160 K
KW - mean (C–C) = 0.002 A°
KW - R factor = 0.041
KW - wR factor = 0.089
KW - data-to-parameter ratio = 18.0
KW - parallel crystallization
KW - packing motifs
KW - carbamazepine
KW - 10
KW - 11-dihydrocarbamazepine
KW - patterns
U2 - 10.1107/S1600536808018059
DO - 10.1107/S1600536808018059
M3 - Article
VL - 64
SP - O1295-U2200
JO - Acta Crystallographica Section E: Structure Reports
T2 - Acta Crystallographica Section E: Structure Reports
JF - Acta Crystallographica Section E: Structure Reports
SN - 1600-5368
IS - 7
ER -